Search Results

FACT-En Functional Assessment of Cancer Therapy – Endometrial For patients with Endometrial cancer LICENSE THIS MEASURE Overview Language Availability Licensing Selected References Related Measures Overview Overview Below are the details for the FACT-En measure: MEASURE NAME: Functional Assessment of Cancer Therapy – Endometrial (FACT-En) VERSION: 4 NUMBER OF ITEMS: 43 PATIENT POPULATION: Endometrial cancer patients 18 years and older RECALL PERIOD: Past 7 days RESPONSE SCALE: 5 point Likert-type scale DATA COLLECTION: Paper and electronic ADMINISTRATION: Self-administration and interview when applicable SUBSCALE DOMAINS: Physical Well-Being, Social/Family Well-Being, Emotional Well-Being, Functional Well-Being, Endometrial Cancer Subscale TIME FOR COMPLETION: 10-15 minutes SCORING: Manual scoring template, some items are reverse scored. Subscale scores, total scores and TOI scores possible. SAS/SPSS algorithms available. RELATED MEASURES: FACT-Cx , FACT-V , FACT-O DOWNLOAD MEASURE IN ENGLISH DOWNLOAD SCORING DOCUMENT Language Availability Available translations of the FACT-En can be obtained by registering for permission. Users are not permitted to translate the FACT-En without permission from FACIT.org. Permission from FACIT.org to translate the FACT-En may also be contingent upon timeline expectations and availability of FACIT staff. Translations must undergo a rigorous methodology under the guidance of FACIT.org which includes multiple translators, QA steps and cognitive interviews with patients. For commercial use, FACITtrans is the approved translation vendor to translate the FACIT measurement system. Please contact us for more information. VIEW AVAILABLE LANGUAGES Language Availability Licensing Licensing Licensing fees are assessed on a per trial/per measure basis for commercial use. There is no fee for use of the English version, but a license should be obtained. Non-commercial use is assessed on a case-by-case basis. Licensing fees are typically not applied to investigator-initiated research, students, or clinical use. To license an available version of this measure for commercial or non-commercial use, please complete our registration form . All of the information provided in the form will be kept strictly confidential. For questions, please contact us . LICENSE THIS MEASURE Selected References Selected References Bonomi, A.E., Cella, D.D., Hahn, E.A., Bjordal, K., Sperner, B., Gangeri, L., Bergman, B., Willems, J., Hanquet, P., & Zittoun, R. Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) quality of life measurement system. Quality of Life Research 1996; 5: 309-320. Eremenco, S., Arnold, B., Cella, D. A comprehensive method for the translation and cross-cultural validation of health status questionnaires. Evaluation & the Health Professions 2005; 28(2): 212-232. Webster K., Cella D., Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: Properties applications, and interpretation. Health and Quality of Life Outcomes 2003; 1(1): 79-85. Yost K.J., Eton D.T. Combining distribution- and anchor-based approaches to determine minimally important differences: The FACIT experience. Evaluation & the Health Professions 2005; 28(2): 172-191. LICENSE THIS MEASURE Related Measures Related Measures FACT-Cx Functional Assessment of Cancer Therapy – Cervix LEARN MORE FACT-V Functional Assessment of Cancer Therapy – Vulva LEARN MORE FACT-O Functional Assessment of Cancer Therapy – Ovarian LEARN MORE

View all available languages for this measure. BACK FACIT-Sp-12 Languages Arabic Bengali Burmese Chinese - Traditional Chinese - Simplified Croatian Czech Danish Dutch English Farsi French German Greek Hebrew Hindi Hungarian Indonesian Italian Japanese Korean Lithuanian Malay Malayalam Marathi Nepali Norwegian Polish Portuguese Serbian Sinhala Spanish Slovak Slovene Swahili Swedish Tamil Telugu Thai Turkish Vietnamese

FACT-Th18 Functional Assessment of Cancer Therapy - Thrombocytopenia 18 Item Version For patients with Thrombocytopenia LICENSE THIS MEASURE Overview Language Availability Licensing Selected References Related Measures Overview Overview Below are the details for the FACT-Th18 measure: MEASURE NAME: Functional Assessment of Cancer Therapy - Thrombocytopenia 18 Item Version (FACT-Th18) VERSION: 4 NUMBER OF ITEMS: 45 PATIENT POPULATION: Cancer patients 18 and older with thrombocytopenia RECALL PERIOD: Past 7 days RESPONSE SCALE: 5 point Likert-type scale DATA COLLECTION: Paper and electronic ADMINISTRATION: Self-administration and interview when applicable SUBSCALE DOMAINS: Physical Well-Being, Social/Family Well-Being, Emotional Well-Being, Functional Well-Being, Thrombocytopenia Subscale TIME FOR COMPLETION: 10-15 minutes SCORING: Manual scoring template, some items are reverse scored. Subscale scores, total scores and TOI scores possible. SAS/SPSS algorithms available. RELATED MEASURES: FACT-Th6 , FACT-Th11 , FACT-G DOWNLOAD MEASURE IN ENGLISH DOWNLOAD SCORING DOCUMENT Language Availability Available translations of the FACT-Th18 can be obtained by registering for permission. Users are not permitted to translate the FACT-Th18 without permission from FACIT.org. Permission from FACIT.org to translate the FACT-Th18 may also be contingent upon timeline expectations and availability of FACIT staff. Translations must undergo a rigorous methodology under the guidance of FACIT.org which includes multiple translators, QA steps and cognitive interviews with patients. For commercial use, FACITtrans is the approved translation vendor to translate the FACIT measurement system. Please contact us for more information. VIEW AVAILABLE LANGUAGES Language Availability Licensing Licensing Licensing fees are assessed on a per trial/per measure basis for commercial use. There is no fee for use of the English version, but a license should be obtained. Non-commercial use is assessed on a case-by-case basis. Licensing fees are typically not applied to investigator-initiated research, students, or clinical use. To license an available version of this measure for commercial or non-commercial use, please complete our registration form . All of the information provided in the form will be kept strictly confidential. For questions, please contact us . LICENSE THIS MEASURE Selected References Selected References Bonomi, A.E., Cella, D.D., Hahn, E.A., Bjordal, K., Sperner, B., Gangeri, L., Bergman, B., Willems, J., Hanquet, P., & Zittoun, R. Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) quality of life measurement system. Quality of Life Research 1996; 5: 309-320. Eremenco, S., Arnold, B., Cella, D. A comprehensive method for the translation and cross-cultural validation of health status questionnaires. Evaluation & the Health Professions 2005; 28(2): 212-232. Webster K., Cella D., Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: Properties applications, and interpretation. Health and Quality of Life Outcomes 2003; 1(1): 79-85. Yost K.J., Eton D.T. Combining distribution- and anchor-based approaches to determine minimally important differences: The FACIT experience. Evaluation & the Health Professions 2005; 28(2): 172-191. LICENSE THIS MEASURE Related Measures Related Measures FACT-Th6 Functional Assessment of Cancer Therapy - Thrombocytopenia 6 Item Version LEARN MORE FACT-Th11 Functional Assessment of Cancer Therapy - Thrombocytopenia 11 Item Version LEARN MORE FACT-G Functional Assessment of Cancer Therapy – General LEARN MORE

Download this measure in English. BACK PROMIS SF v1.0-Dyspnea-Functional Limitations 5b English Downloads Download PDF Download DOC

View all available languages for this measure. BACK PROMIS Pool v1.0 - Dyspnea Activity Requirements Languages Arabic English

NFBrSI-24 National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Brain Cancer Symptom Index - 24 Item Version For patients with Brain cancer; A FACT/NCCN-Brain Symptom Index LICENSE THIS MEASURE Overview Language Availability Licensing Selected References Related Measures Overview Overview The NCCN-FACT Brain Symptom Index-24 (NFBrSI-24) is an index of the symptoms in advanced brain tumors perceived as most important by both patients and clinicians and improves upon existing measures of brain tumor symptoms through better satisfaction of regulatory requirements for measure development. The findings in development suggest good reliability and validity, indicating that the NFBrSI-24 is a promising brief assessment of high priority advanced brain tumor symptoms for research and clinical settings. MEASURE NAME: National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Brain Cancer Symptom Index - 24 Item Version (NFBrSI-24) VERSION: 2 NUMBER OF ITEMS: 24 PATIENT POPULATION: Brain cancer patients 18 years and older RECALL PERIOD: Past 7 days RESPONSE SCALE: 5 point Likert-type scale DATA COLLECTION: Paper and electronic ADMINISTRATION: Self-administration and interview when applicable SUBSCALE DOMAINS: Disease-Related Symptoms – Physical, Disease-Related Symptoms – Emotional, Treatment Side-Effects, Function/Well-Being TIME FOR COMPLETION: 5-10 minutes SCORING: Manual scoring template, some items are reverse scored. Subscale scores and total scores possible. RELATED MEASURES: FACT-Br , FBrSI , FACT-G DOWNLOAD MEASURE IN ENGLISH DOWNLOAD SCORING DOCUMENT Language Availability Available translations of the NFBrSI-24 can be obtained by registering for permission. Users are not permitted to translate the NFBrSI-24 without permission from FACIT.org. Permission from FACIT.org to translate the NFBrSI-24 may also be contingent upon timeline expectations and availability of FACIT staff. Translations must undergo a rigorous methodology under the guidance of FACIT.org which includes multiple translators, QA steps and cognitive interviews with patients. For commercial use, FACITtrans is the approved translation vendor to translate the FACIT measurement system. Please contact us for more information. VIEW AVAILABLE LANGUAGES Language Availability Licensing Licensing Licensing fees are assessed on a per trial/per measure basis for commercial use. There is no fee for use of the English version, but a license should be obtained. Non-commercial use is assessed on a case-by-case basis. Licensing fees are typically not applied to investigator-initiated research, students, or clinical use. To license an available version of this measure for commercial or non-commercial use, please complete our registration form . All of the information provided in the form will be kept strictly confidential. For questions, please contact us . LICENSE THIS MEASURE Selected References Selected References Cella, D., Paul, D., Yount, S., Winn, R., Chang, C-H, Banik, D., & Weeks, J. What are the most important symptom targets when treating advanced cancer? A survey of providers in the National Comprehensive Cancer Network (NCCN). Cancer Investigation 2003; 21(4): 526-535. doi: 10.108/CNV-120022366. Cella, D., Rosenbloom, S., Beaumont, J., Yount, J., Paul, D., Hampton, D., Abernethy, A., Jacobsen, P., Syrjala, K., & Von Roenn, J. Development and validation of 11 symptom indexes to evaluate response to chemotherapy for advanced cancer. Journal of the National Comprehensive Cancer Network; 2011; 9(3): 268-278. doi: 10.6004/jnccn.2011.0026. Lai, J-S. Cella, D. Beaumont, J., Jensen, S. Development of a Symptom Index for Patients with Primary Brain Tumors. Value in Health 2014; 17: 62-69. doi: 10.1016/j.jval.2013.11.006. Rosenbloom, S., Yount, S., Yost, K., Hampton, D., Paul, D., Abernethy, A., Jacobsen, P., Syrjala, K., Von Roenn, J., & Cella, D. Development and validation of eleven symptom indices to evaluate response to chemotherapy for advanced cancer: Measurement compliance with regulatory demands. Farquhar, I., Summers, K., Sorkin, A. (Eds.). The Value of Innovation: Impacts on Health, Life Quality and Regulatory Research. Emerald Group Publishing Inc. 2007; 16: 53-66. doi: 10.1016/S0194-3960(08)16003-6. Bonomi, A.E., Cella, D.D., Hahn, E.A., Bjordal, K., Sperner, B., Gangeri, L., Bergman, B., Willems, J., Hanquet, P., & Zittoun, R. Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) quality of life measurement system. Quality of Life Research 1996; 5: 309-320. Eremenco, S., Arnold, B., Cella, D. A comprehensive method for the translation and cross-cultural validation of health status questionnaires. Evaluation & the Health Professions 2005; 28(2): 212-232. Webster K., Cella D., Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: Properties applications, and interpretation. Health and Quality of Life Outcomes 2003; 1(1): 79-85. Yost K.J., Eton D.T. Combining distribution- and anchor-based approaches to determine minimally important differences: The FACIT experience. Evaluation & the Health Professions 2005; 28(2): 172-191. LICENSE THIS MEASURE Related Measures Related Measures FACT-Br Functional Assessment of Cancer Therapy – Brain LEARN MORE FBrSI Functional Assessment of Cancer Therapy Brain Cancer Symptom Index - 15 Item Version LEARN MORE FACT-G Functional Assessment of Cancer Therapy – General LEARN MORE

PROMIS Pool v1.0 - Dyspnea Activity Requirements Patient Reported Outcomes Measurement Information System Pool - Dyspnea Activity Requirements For patients with dyspnea LICENSE THIS MEASURE Overview Language Availability Licensing Selected References Related Measures Overview Overview Below are the details on the PROMIS Pool v1.0 Dyspnea Activity Requirements MEASURE NAME: PROMIS Pool v1.0 - Dyspnea Activity Requirements VERSION: 1 NUMBER OF ITEMS: 4 PATIENT POPULATION: Dyspnea patients 18 years and older RECALL PERIOD: Past month RESPONSE SCALE: Yes/No DATA COLLECTION: Paper and electronic For permission to implement and administer the measure electronically, please visit: https://www.healthmeasures.net/implement-healthmeasures/administration-platforms ADMINISTRATION: Self-administration and interview when applicable SUBSCALE DOMAINS: Activity Requirements TIME FOR COMPLETION: Less than 5 minutes SCORING: PROMIS Scoring Service: http://www.healthmeasures.net/score-and-interpret/calculate-scores/scoring-instructions RELATED MEASURES: FACIT-Dyspnea , PROMIS Pool v1.0 - Dyspnea Activity Motivation , PROMIS Pool v1.0 - Dyspnea Airborne Exposure DOWNLOAD MEASURE IN ENGLISH DOWNLOAD SCORING DOCUMENT Language Availability Available translations of the PROMIS Pool v1.0 - Dyspnea Activity Requirements can be obtained by registering for permission. Users are not permitted to translate the PROMIS Pool v1.0 - Dyspnea Activity Requirements without permission from FACIT.org. Permission from FACIT.org to translate the PROMIS Pool v1.0 - Dyspnea Activity Requirements may also be contingent upon timeline expectations and availability of FACIT staff. Translations must undergo a rigorous methodology under the guidance of FACIT.org which includes multiple translators, QA steps and cognitive interviews with patients. For commercial use, FACITtrans is the approved translation vendor to translate the FACIT measurement system. Please contact us for more information. VIEW AVAILABLE LANGUAGES Language Availability Licensing Licensing Licensing fees are assessed on a per trial/per measure basis for commercial use. There is no fee for use of the English version, but a license should be obtained. Non-commercial use is assessed on a case-by-case basis. Licensing fees are typically not applied to investigator-initiated research, students, or clinical use. To license an available version of this measure for commercial or non-commercial use, please complete our registration form . All of the information provided in the form will be kept strictly confidential. For questions, please contact us . LICENSE THIS MEASURE Selected References Selected References Choi, S., Victorson, D., Yount, S., Anton, S., & Cella, D. Development of a conceptual framework and calibrated item banks to measure patient reported dyspnea severity and related functional limitations. Value in Health 2011; 14: 291-306. Ruo, B., Choi, S., Baker, D., Grady, K., & Cella,D. Development and validation of a computer adaptive test measuring dyspnea in heart failure. Journal of Cardiac Failure 2010; 16(8): 659-668. doi: 10.1016/j.cardfail.2010.03.002. Victorson, D., Anton, S., Hamilton, A., Yount, S., & Cella, D. A conceptual model of the experience of dyspnea and functional limitations in COPD. Value in Health 2009; 12(6): 1018-1025. Yount, S., Choi, S., Victorson, D., Ruo, B., Ray, D., Cella, D., Anton, S., & Hamilton, A. (2011) Brief, valid measures of dyspnea and related functional limitations in chronic obstructive pulmonary disease (COPD). Value in Health 2011; 14: 307-315. Bonomi, A.E., Cella, D.D., Hahn, E.A., Bjordal, K., Sperner, B., Gangeri, L., Bergman, B., Willems, J., Hanquet, P., & Zittoun, R. Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) quality of life measurement system. Quality of Life Research 1996; 5: 309-320. Eremenco, S., Arnold, B., Cella, D. A comprehensive method for the translation and cross-cultural validation of health status questionnaires. Evaluation & the Health Professions 2005; 28(2): 212-232. Webster K., Cella D., Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: Properties applications, and interpretation. Health and Quality of Life Outcomes 2003; 1(1): 79-85. Yost K.J., Eton D.T. Combining distribution- and anchor-based approaches to determine minimally important differences: The FACIT experience. Evaluation & the Health Professions 2005; 28(2): 172-191. LICENSE THIS MEASURE Related Measures Related Measures FACIT-Dyspnea Functional Assessment of Chronic Illness Therapy - Dyspnea-10 item LEARN MORE PROMIS Pool v1.0 - Dyspnea Activity Motivation Patient-Reported Outcomes Measurement Information System Pool - Dyspnea Activity Motivation LEARN MORE PROMIS Pool v1.0 - Dyspnea Airborne Exposure Patient-Reported Outcomes Measurement Information System Pool - Dyspnea Airborne Exposure LEARN MORE

Download scoring documents for this measure. BACK FACT-Br Scoring Downloads Download DOC

Download scoring documents for this measure. BACK FACIT-Dyspnea Scoring Downloads Download DOC

Download scoring documents for this measure. BACK FACT-G7 Scoring Downloads Download DOC

FACT-B Functional Assessment of Cancer Therapy – Breast For patients with Breast cancer LICENSE THIS MEASURE Overview Language Availability Licensing Selected References Related Measures Overview Overview The Functional Assessment of Cancer Therapy - Breast (FACT-B) is a 37-item instrument designed to measure five domains of HRQOL in breast cancer patients: Physical, social, emotional, functional well-being as well as a breast-cancer subscale (BCS). Utilized with the 27 core FACT-G items, the FACT-B was developed with an emphasis on patients’ values and brevity. Initial validation involved two patient samples. The first was tested twice over a 2-month period to assess sensitivity to change. Significant sensitivity to change in performance status rating (PSR) was demonstrated for the FACT-B total score, the Physical Well-Being (PWB) subscale, the Functional Well-Being (FWB) subscale, and the BCS. Sensitivity to change in QL as measured by the Functional Living Index-Cancer (FLIC) was documented in the FACT-B total score, PWB, FWB, and Emotional Well-Being (EWB). Additional validity and reliability data were obtained from a larger sample. The alpha coefficient (internal consistency) for the FACT-B total score was high (a = .90), with subscale alpha coefficients ranging from .63 to .86. Evidence supported test-retest reliability, as well as convergent, divergent, and known groups validity. MEASURE NAME: Functional Assessment of Cancer Therapy – Breast (FACT-B) VERSION: 4 NUMBER OF ITEMS: 37 PATIENT POPULATION: Breast cancer patients 18 years and older RECALL PERIOD: Past 7 days RESPONSE SCALE: 5 point Likert-type scale DATA COLLECTION: Paper and electronic ADMINISTRATION: Self-administration and interview when applicable SUBSCALE DOMAINS: Physical Well-Being, Social/Family Well-Being, Emotional Well-Being, Functional Well-Being, Breast Cancer Subscale TIME FOR COMPLETION: 10-15 minutes SCORING: Manual scoring template, some items are reverse scored. Subscale scores, total scores and TOI possible. SAS/SPSS algorithms available. RELATED MEASURES: NFBSI-16 , FBSI , FACT-B+4 DOWNLOAD MEASURE IN ENGLISH DOWNLOAD SCORING DOCUMENT Language Availability Available translations of the FACT-B can be obtained by registering for permission. Users are not permitted to translate the FACT-B without permission from FACIT.org. Permission from FACIT.org to translate the FACT-B may also be contingent upon timeline expectations and availability of FACIT staff. Translations must undergo a rigorous methodology under the guidance of FACIT.org which includes multiple translators, QA steps and cognitive interviews with patients. For commercial use, FACITtrans is the approved translation vendor to translate the FACIT measurement system. Please contact us for more information. VIEW AVAILABLE LANGUAGES Language Availability Licensing Licensing Licensing fees are assessed on a per trial/per measure basis for commercial use. There is no fee for use of the English version, but a license should be obtained. Non-commercial use is assessed on a case-by-case basis. Licensing fees are typically not applied to investigator-initiated research, students, or clinical use. To license an available version of this measure for commercial or non-commercial use, please complete our registration form . All of the information provided in the form will be kept strictly confidential. For questions, please contact us . LICENSE THIS MEASURE Selected References Selected References Brady M.J., Cella D.F., Mo F., Bonomi A.E., Tulsky D.S., Lloyd S.R., Deasy S., Cobleigh M., Shiomoto G. Reliability and validity of the Functional Assessment of Cancer Therapy – Breast quality-of-life instrument. Journal of Clinical Oncology 1997; 15(3): 974-986. Bonomi, A.E., Cella, D.D., Hahn, E.A., Bjordal, K., Sperner, B., Gangeri, L., Bergman, B., Willems, J., Hanquet, P., & Zittoun, R. Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) quality of life measurement system. Quality of Life Research 1996; 5: 309-320. Cella D., Land S.R., Chang C.H., Day R., Costantino J.P., Wolmark N., Ganz P.A. Symptom measurement in the Breast Cancer Prevention Trial (BCPT) (P-1): Psychometric properties of a new measure of symptoms for midlife women. Breast Cancer Research and Treatment 2008; 109: 515-526. Eremenco, S., Arnold, B., Cella, D. A comprehensive method for the translation and cross-cultural validation of health status questionnaires. Evaluation & the Health Professions 2005; 28(2): 212-232. Eton D.T., Cella D., Yost K.J., Yount S.E., Peterman A.H., Neuberg D.S., Sledge G.W., Wood W.C. A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale. Journal of Clinical Epidemiology 2004; 57: 898-910. Hahn, E.A., Holzner, B., Kemmler, G., Sperner-Unterweger, B., Hudgens, S., Cella, D. Cross-cultural evaluation of health status using item response theory: FACT-B comparisons between Austrian and U.S. breast cancer patients. Evaluation & the Health Professions 2005; 28(2): 233-259. Henderson V.P., Massion A.O., Druker S. The effects of mindfulness-based stress reduction on psychosocial outcomes and quality of life in early-stage breast cancer patients: A randomized trial. Breast Cancer Research and Treatment 2012; 131: 99-109. Kugbey, N., Meyer-Weitz, A., & Oppong Asante, K. Access to health information, health literacy and health-related quality of life among women living with breast cancer: Depression and anxiety as mediators. Patient Education and Counseling 2019; 102(7): 1357-1363. doi: 10.1016/j.pec.2019.02.014. Kugbey, N., Meyer-Weitz, A., & Oppong Asante, K. Mental adjustment to cancer and quality of life among women living with breast cancer in Ghana. The International Journal of Psychiatry in Medicine 2019; 54(3): 217-230. doi: : 10.1177/0091217418805087. Kugbey, N., Oppong Asante, K., & Meyer-Weitz, A. Doctor–patient relationship mediates the effects of shared decision making on health-related quality of life among women living with breast cancer. South African Journal of Psychology 2019; 49(3); 364–375. doi: 10.1177/0081246318801. Kugbey, N., Oppong Asante, K., & Meyer-Weitz, A. Depression, anxiety and quality of life among women living with breast cancer in Ghana: mediating roles of social support and religiosity. Supportive Care in Cancer 2019; 1-8. doi: 10.1007/s00520-019-05027-1. Lemieux J., Goodwin P.J., Bordeleau L.J., Lauzier S., Théberge V. Quality-of-life measurement in randomized clinical trials in breast cancer: An updated systematic review (2001-2009). Journal of the National Cancer Institute 2011; 103(3): 178-231. Pandey M., Thomas B.C., Ramdas K., Eremenco S., Nair M.K. Quality of life in breast cancer patients: Validation of a FACT-B Malayalam version. Quality of Life Research 2002; 11: 87-90. Thomas R., Godward S., Makris A., Bloomfield D., Moody A.M., Williams M. Giving patients a choice improves quality of life: A multi-centre, investigator-blind, randomized, crossover study comparing Letrozole and Anastrozole. Clinical Oncology 2004; 16: 485-491. Ursini LA, Nuzzo M, Rosa C, DI Guglielmo FC, DI Tommaso M, Trignani M, Borgia M, Allajbej A, Patani F, DI Carlo C, Porreca A, DI Nicola M, Genovesi D, Caravatta L. Quality of Life in Early Breast Cancer Patients: A Prospective Observational Study Using the FACT-B Questionnaire. In Vivo. 2021 May-Jun;35(3):1821-1828. doi: 10.21873/invivo.12443. PMID: 33910868. Webster K., Cella D., Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: Properties applications, and interpretation. Health and Quality of Life Outcomes 2003; 1(1): 79-85. Yost K.J., Eton D.T. Combining distribution- and anchor-based approaches to determine minimally important differences: The FACIT experience. Evaluation & the Health Professions 2005; 28(2): 172-191. LICENSE THIS MEASURE Related Measures Related Measures NFBSI-16 National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Breast Cancer Symptom Index - 16 Item Version LEARN MORE FBSI Functional Assessment of Cancer Therapy - Breast Symptom Index LEARN MORE FACT-B+4 Functional Assessment of Cancer Therapy – Lymphedema LEARN MORE

Download scoring documents for this measure. BACK FACT-N Scoring Downloads Download DOC